Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-024317

Chief Scientific Officer sold 3,000 shares at an average $75.20 ($225,607)

  • Chief Scientific Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2018-04-05 Option exercise +3,000 $9.05 $27,150 60,196 D
Biller Scott Chief Scientific Officer 2018-04-05 Sale −1,300 $73.90 $96,070 58,896 D
Biller Scott Chief Scientific Officer 2018-04-05 Sale −400 $75.04 $30,016 58,496 D
Biller Scott Chief Scientific Officer 2018-04-05 Sale −800 $76.17 $60,936 57,696 D
Biller Scott Chief Scientific Officer 2018-04-05 Sale −500 $77.17 $38,585 57,196 D
Derivatives
Biller Scott Chief Scientific Officer 2018-04-05 Option exercise · Stock options (right to buy) +3,000 25,154 D
Open-market sales · 3,000 sh · avg $75.20 · $225,607
Loading xslF345X03/doc4.xml…